Saliva: potential diagnostic value and transmission of 2019-nCoV

Abstract

2019-nCoV epidemic was firstly reported at late December of 2019 and has caused a global outbreak of COVID-19 now. Saliva, a biofluid largely generated from salivary glands in oral cavity, has been reported 2019-nCoV nucleic acid positive. Besides lungs, salivary glands and tongue are possibly another hosts of 2019-nCoV due to expression of ACE2. Close contact or short-range transmission of infectious saliva droplets is a primary mode for 2019-nCoV to disseminate as claimed by WHO, while long-distance saliva aerosol transmission is highly environment dependent within indoor space with aerosol-generating procedures such as dental practice. So far, no direct evidence has been found that 2019-nCoV is vital in air flow for long time. Therefore, to prevent formation of infectious saliva droplets, to thoroughly disinfect indoor air and to block acquisition of saliva droplets could slow down 2019-nCoV dissemination. This review summarizes diagnostic value of saliva for 2019-nCoV, possibly direct invasion into oral tissues, and close contact transmission of 2019-nCoV by saliva droplets, expecting to contribute to 2019-nCoV epidemic control.

References

[1] Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet, 2020, 395: 470-473.

[2] Zhu N, . A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med., 2020, 382: 727-733.

[3] Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol., 2019, 17: 181-192.

[4] Wong G, . MERS, SARS, and Ebola: the role of super-spreaders in infectious disease. Cell Host Microbe, 2015, 18: 398-401.

[5] Bai Y., Nie X. & Wen C. Epidemic Prediction of 2019-nCoV in Hubei Province and Comparison With SARS in Guangdong Province. https://ssrn.com/abstract=3531427 (2020).

[6] Spielmann N, Wong DT. Saliva: diagnostics and therapeutic perspectives. Oral. Dis., 2011, 17: 345-354.

[7] Navazesh M, Kumar SK University of Southern California School of Dentistry. Measuring salivary flow: challenges and opportunities. J. Am. Dent. Assoc., 2008, 139(Suppl): 35S-40S.

[8] Kaufman E, Lamster IB. The diagnostic applications of saliva-a review. Crit. Rev. Oral. Biol. Med., 2002, 13: 197-212.

[9] Zhang CZ, . Saliva in the diagnosis of diseases. Int J. Oral. Sci., 2016, 8: 133-137.

[10] General Office of the National Health Commission, General Office of the Nation Administration of Traditional Chinese Medicine. Notice on issuing the pneumonia diagnosis and treatment plan for the new coronavirus infection (The 7th Trial Edition). (2020).

[11] To, K. K. et al. Consistent detection of 2019 novel coronavirus in saliva. Clin. Infect. Dis. https://doi.org/10.1093/cid/ciaa149 (2020).

[12] To, K. K.-W. et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect. Dis. https://doi.org/10.1016/s1473-3099(20)30196-1 (2020).

[13] Zhang W, . Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg. Microbes Infect., 2020, 9: 386-389.

[14] Chen, L. et al. Detection of 2019-nCoV in Saliva and Characterization of Oral Symptoms in COVID-19 Patients. https://ssrn.com/abstract=3557140 (2020).

[15] Mostafa, A., Abdelwhab, E. M., Mettenleiter, T. C. & Pleschka, S. Zoonotic potential of influenza A viruses: a comprehensive overview. Viruses 10, (2018). https://doi.org/10.3390/v10090497.

[16] Maginnis MS. Virus-receptor interactions: the key to cellular invasion. J. Mol. Biol., 2018, 430: 2590-2611.

[17] Zhou P, . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 2020, 579: 270-273.

[18] Li W, . Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature, 2003, 426: 450-454.

[19] Hofmann H, . Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc. Natl Acad. Sci. USA, 2005, 102: 7988-7993.

[20] Xu X, . Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci. China Life Sci., 2020, 63: 457-460.

[21] Wrapp D, . Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science, 2020, 367: 1260-1263.

[22] Zhang, H. et al. The Digestive System is a Potential Route of 2019-nCov Infection: A Bioinformatics Analysis Based on Single-cell Transcriptomes. https://doi.org/10.1101/2020.01.30.927806 (2020).

[23] Zhao, Y. et al. Single-Cell RNA Expression Profiling of ACE2, the Putative Receptor of Wuhan 2019-nCov. https://doi.org/10.1101/2020.01.26.919985 (2020).

[24] Zou, X. et al. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front. Med. https://doi.org/10.1007/s11684-020-0754-0 (2020).

[25] Chai, X. et al. Specific ACE2 Expression in Cholangiocytes may Cause Liver Damage After 2019-nCoV Infection. https://doi.org/10.1101/2020.02.03.931766 (2020).

[26] Chan JF, . A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet, 2020, 395: 514-523.

[27] Holshue ML, . First case of 2019 novel coronavirus in the United States. N. Engl. J. Med., 2020, 382: 929-936.

[28] Liang, W. et al. Diarrhoea may be underestimated: a missing link in 2019 novel coronavirus. Gut. https://doi.org/10.1136/gutjnl-2020-320832 (2020).

[29] Xu H, . High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J. Oral. Sci., 2020, 12: 8.

[30] Liu L, . Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques. J. Virol., 2011, 85: 4025-4030.

[31] Kessler AT, Bhatt AA. Review of the major and minor salivary glands, part 1: anatomy, infectious, and inflammatory processes. J. Clin. Imaging Sci., 2018, 8: 47.

[32] Izaguirre, G. The proteolytic regulation of virus cell entry by furin and other proprotein convertases. Viruses 11, https://doi.org/10.3390/v11090837 (2019).

[33] Coutard B, . The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antivir. Res., 2020, 176: 104742.

[34] Li, X. D. et al. A Furin Cleavage Site was Discovered in the S Protein of the Wuhan 2019 Novel Coronavirus. www.chinaxiv.org/abs/202002.00004 (2020).

[35] Bassi DE, Zhang J, Renner C, Klein-Szanto AJ. Targeting proprotein convertases in furin-rich lung cancer cells results in decreased in vitro and in vivo growth. Mol. Carcinog., 2017, 56: 1182-1188.

[36] Mallapaty S. Why does the coronavirus spread so easily between people?. Nature, 2020, 579: 183.

[37] Lopez de Cicco R, Watson JC, Bassi DE, Litwin S, Klein-Szanto AJ. Simultaneous expression of furin and vascular endothelial growth factor in human oral tongue squamous cell carcinoma progression. Clin. Cancer Res., 2004, 10: 4480-4488.

[38] WHO. The First Few X Cases and Contact Investigation Protocol for 2019-Novel Coronavirus Infection. https://www.who.com.au/2019-nCoV/FFXprotocol/2020 (2020).

[39] Tang JW, Li Y, Eames I, Chan PK, Ridgway GL. Factors involved in the aerosol transmission of infection and control of ventilation in healthcare premises. J. Hosp. Infect., 2006, 64: 100-114.

[40] Roy CJ, Milton DK. Airborne transmission of communicable infection-the elusive pathway. N. Engl. J. Med., 2004, 350: 1710-1712.

[41] Chapin CV. The importance of contact infection. Am. J. Public Hyg., 1910, 20: 742-759.

[42] Fennelly KP, . Cough-generated aerosols of Mycobacterium tuberculosis: a new method to study infectiousness. Am. J. Respir. Crit. Care Med., 2004, 169: 604-609.

[43] Kohn WG, . Guidelines for infection control in dental health-care settings-2003. MMWR Recomm. Rep., 2003, 52: 1-61.

[44] Edwards DA, . Inhaling to mitigate exhaled bioaerosols. Proc. Natl Acad. Sci. USA, 2004, 101: 17383-17388.

[45] Cole EC, Cook CE. Characterization of infectious aerosols in health care facilities: an aid to effective engineering controls and preventive strategies. Am. J. Infect. Control, 1998, 26: 453-464.

[46] Sehulster L, Chinn RY. Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm. Rep., 2003, 52: 1-42.

[47] Peng X, . Transmission routes of 2019-nCoV and controls in dental practice. Int J. Oral Sci., 2020, 12: 9.

[48] Tang JW, . Door-opening motion can potentially lead to a transient breakdown in negative-pressure isolation conditions: the importance of vorticity and buoyancy airflows. J. Hosp. Infect., 2005, 61: 283-286.

[49] Fitzgerald, D. W., Sterling, T. R. & Haas, D. W. Mycobacterium tuberculosis. In: Mandell, G. L., Bennett, J. E. & Dolin, R. (Eds). Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. Seventh edition (Philadelphia, PA, Churchill Livingstone Elsevier, 2010).

[50] Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J. Hosp. Infect., 2020, 104: 246-251.

[51] Liu, Y. et al. Aerodynamic Characteristics and RNA Concentration of SARS-CoV-2 Aerosol in Wuhan Hospitals during COVID-19 Outbreak. https://doi.org/10.1101/2020.03.08.982637 (2020).

[52] Wong TW, . Cluster of SARS among medical students exposed to single patient, Hong Kong. Emerg. Infect. Dis., 2004, 10: 269-276.

[53] Lu CW, Liu XF, Jia ZF. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet, 2020, 395: e39.

[54] Peiris JS, Yuen KY, Osterhaus AD, Stohr K. The severe acute respiratory syndrome. N. Engl. J. Med., 2003, 349: 2431-2441.

[55] Belser JA, Rota PA, Tumpey TM. Ocular tropism of respiratory viruses. Microbiol Mol. Biol. Rev., 2013, 77: 144-156.

[56] Seto WH, . Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet, 2003, 361: 1519-1520.

[57] Gorbalenya, A. E. et al. Severe acute respiratory syndrome-related coronavirus: the species and its viruses—a statement of the Coronavirus Study Group. Preprint at https://www.biorxiv.org/content/, https://doi.org/10.1101/2020.02.07.937862v1 (2020).

[58] Chen N, . Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 2020, 395: 507-513.

[59] Li, Q. et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2001316 (2020).

[60] de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat. Rev. Microbiol., 2016, 14: 523-534.

[61] Al-Tawfiq JA, Zumla A, Memish ZA. Coronaviruses: severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus in travelers. Curr. Opin. Infect. Dis., 2014, 27: 411-417.

[62] Wang WK, . Detection of SARS-associated coronavirus in throat wash and saliva in early diagnosis. Emerg. Infect. Dis., 2004, 10: 1213-1219.

[63] Qin C, . An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus. J. Pathol., 2005, 206: 251-259.

[64] Perlman S, Netland J. Coronaviruses post-SARS: update on replication and pathogenesis. Nat. Rev. Microbiol., 2009, 7: 439-450.

[65] Huang C, . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020, 395: 497-506.

[66] Peiris JS, . Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet, 2003, 361: 1767-1772.

[67] Oh MD, . Viral load kinetics of MERS coronavirus infection. N. Engl. J. Med., 2016, 375: 1303-1305.

[68] Chu CM, . Initial viral load and the outcomes of SARS. CMAJ, 2004, 171: 1349-1352.

[69] Chen WJ, . Nasopharyngeal shedding of severe acute respiratory syndrome-associated coronavirus is associated with genetic polymorphisms. Clin. Infect. Dis., 2006, 42: 1561-1569.

[70] He, J., Tao, H., Yan, Y., Huang, S.-Y. & Xiao, Y. Molecular Mechanism of Evolution and Human Infection With the Novel Coronavirus (2019-nCoV). https://doi.org/10.1101/2020.02.17.952903 (2020).

[71] Yu IT, . Evidence of airborne transmission of the severe acute respiratory syndrome virus. N. Engl. J. Med., 2004, 350: 1731-1739.

[72] Li Y, Duan S, Yu IT, Wong TW. Multi-zone modeling of probable SARS virus transmission by airflow between flats in Block E, Amoy Gardens. Indoor Air, 2005, 15: 96-111.

[73] van Doremalen, N. et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N. Engl. J. Med. https://doi.org/10.1056/NEJMc2004973 (2020).

[74] WHO. Infection Prevention and Control of Epidemic- and Pandemic-prone Acute Respiratory Infections in Health Care (World Health Organization, 2014).

[75] Su J. [Aerosol transmission risk and comprehensive prevention and control strategy in dental treatment]. Zhonghua Kou Qiang Yi Xue Za Zhi, 2020, 55: E006.

Funding

China Postdoctoral Science Foundation(BX20190224)

Covidien

Special Funds for Prevention and Control of COVID-19 of Sichuan University (2020scunCoV-10008)